Top News

• Alternative Facility Assessment Tools Guidance
• CBER Says AstraZeneca FluMist Ad Misled Viewers
• Respironics Recalls DreamStation Ventilators
• Makary JAMA Piece Explains DTC Ad Crackdown
• CBER to Host Gene Therapy Manufacturing Town Hall
• FDA Pushes Plan to Scale Back Advisory Committees
• Intercept Withdraws Ocaliva Amid Liver Safety Concerns
• Ways FDA Can Modernize Drug Development